Journal
TRENDS IN PARASITOLOGY
Volume 34, Issue 2, Pages 114-126Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.pt.2017.10.009
Keywords
-
Categories
Funding
- Bill and Melinda Gates Foundation [1023643]
- NIH [R01AI064478]
- Division of Intramural Research, National Institutes of Health, USA
- National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA
- NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064478] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Malaria prevalence has declined in the past 10 years, especially outside of sub-Saharan Africa. However, the proportion of cases due to Plasmodium vivax is increasing, accounting for up to 90-100% of the malaria burden in endemic regions. Nonetheless, investments in malaria research and control still prioritize Plasmodium falciparum while largely neglecting P. vivax. Specific biological features of P. vivax, particularly invasion of reticulocytes, occurrence of dormant liver forms of the parasite, and the potential for transmission of sexual-stage parasites prior to onset of clinical illness, promote its persistence and hinder development of research tools and interventions. This review discusses recent advances in P. vivax research, current knowledge of its unique biology, and proposes priorities for P. vivax research and control efforts.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available